Dr. Han Lim is the Chief Business Officer at DeepCure. DeepCure is creating an end-to-end automated platform to accelerate and personalize small molecule drug discovery through the integration of AI, a virtual library of a quintillion synthesizable compounds, robotic synthesis, and automated assays. Before joining DeepCure, Dr. Lim was instrumental in building one of the first-generation AI drug discovery companies. His experiences are broad, from target selection and portfolio strategy for AI platforms to biopharma deals and academic collaborations. His previous roles include Chief Business Officer at Atomwise and faculty member at the University of California, Berkeley. Dr. Lim obtained a medical degree from the University of Queensland, a Ph.D. from the University of Cambridge, and postdoctoral training in the Department of Physics at MIT.